Kestra Medical Technologies, Ltd. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Grant/Award: 88,235 shares
Grant/Award
1 txn
Insider
Webster Brian Daniel
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 88,235 | $0.00 | $0.00 |
| Holding | Options | -- | -- | -- |
Holdings After Transaction:
Common Shares — 397,577 shares (Direct);
Options — 1,780,000 options (Direct)
Footnotes (2)
- F1. Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest 29,333 on July 17, 2026, 29,333 on July 17, 2027 and 29,334 on July 17, 2028.
- F2. Includes 1,068,000 fully vested options and 712,000 options that will vest as follows: 356,000 of such options will vest on March 6, 2026, and the remaining 356,000 will vest monthly over the following year.
AI-generated analysis. How Rhea-AI works. Not financial advice.